Added to YB: 2025-12-18
Pitch date: 2025-12-15
SNY [bullish]
Sanofi
-0.18%
current return
Author Info
No bio for this author
Company Info
Sanofi engages in the research, development, manufacture, and marketing of therapeutic solutions. It provides immunology and inflammation, rare diseases, neurology, oncology, and other medicines and vaccines.
Market Cap
EUR 98.1B
Pitch Price
EUR 82.27
Price Target
N/A
Dividend
4.86%
EV/EBITDA
8.73
P/E
15.44
EV/Sales
2.42
Sector
Pharmaceuticals
Category
value
Rotating Out of Winners Into Higher Asymmetry: Why We’re Buying a Healthcare Basket - Sanofi
SNY: Paris pharma w/ Dupixent >€4B quarterly, +7% Q3 sales growth. Amlitelimab hit Phase 3 endpoints in atopic dermatitis. Strong immunology franchise + pipeline building. Forward P/E ~9.8x, 4.5% dividend yield. Discounted multiple on franchise that consistently beats expectations + new launch optionality.
Read full article (1 min)